ORIGINAL RESEARCH article
Front. Genet.
Sec. Statistical Genetics and Methodology
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1572487
This article is part of the Research TopicFunctional Study of Novel VUS (Variant of Uncertain Significance) Mutations in Single-gene Inherited Disease, Volume IIView all articles
A novel synonymous variant in the NF1 gene disrupting splicing contributes to Neurofibromatosis pathogenesis
Provisionally accepted- 1Department of Gynecology and Obstetrics, Wenzhou People's Hospital/Wenzhou Maternal and Child Health Care Hospital, WENZHOU, China
- 2Department of Plastic and Aesthetic Surgery, Wenzhou People's Hospital, wenzhou, China
- 3Department of Reproductive Genetics, Wenzhou People's Hospital/Wenzhou Maternal and Child Health Care Hospital, Wenzhou, Zhejiang Province, China
- 4Key Laboratory of Obstetrics and Gynecology, Wenzhou People’s Hospital, Wenzhou, Zhejiang Province, China
- 5Department of Reproductive Genetics,Women's Hospital,Zhejiang University School of Medicine, hanzhou, China
- 6Department of Reproductive Genetics, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University/Wenzhou Maternal and Child Health Care Hospital, wenzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder characterized by café-au-lait macules, neurofibromas, and other manifestations. It is caused by variations in the NF1 gene located on chromosome 17q11.2. The gene's complexity and extensive variations often lead to misdiagnoses by conventional detection methods, which adverses to effective diagnosis and treatment strategies.Case presentation: A 26-year-old Chinese woman was admitted to our hospital with multiple café-au-lait spots and cutaneous nodules. She had a family history of NF1, with her mother also showing similar dermatological symptoms. Whole exome sequencing (WES) identified a synonymous variation, NM_001042492.3: c.987A>G (p.K329K), in the NF1 gene. Although synonymous variations are typically considered non-pathogenic, RNA sequencing (RNA-seq) and minigene analysis revealed that this variation caused the partial loss of exon 9, leading to aberrant splicing. These findings were validated through Sanger sequencing, confirming the genetic alteration and its impact on mRNA splicing.The case highlights the critical role of synonymous variations in the NF1 gene that significantly impact splicing and protein function. These findings expand our understanding of NF1's genetic diversity and underscore the importance of comprehensive genetic and RNA analyses to achieve accurate diagnosis and in-depth insight into the molecular underpinnings of NF1.
Keywords: neurofibromatosis type 1, NF1, synonymous variation, Splicing variant, Whole-exome sequencing
Received: 07 Feb 2025; Accepted: 01 Apr 2025.
Copyright: © 2025 Lin, Chen, Dong, Pan, Wang, zheng, Chen, lai, Zhang, dong, xu, Lin, XI, xia, wang, Wang, Xiaoqing, Sun, Hu, XU, Zheng, Jin, Zhang and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jiayong Zheng, Key Laboratory of Obstetrics and Gynecology, Wenzhou People’s Hospital, Wenzhou, 325000, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.